B. Helfrich
About
B. Helfrich has authored 27 papers that have received a total of 1.4k indexed citations.
This includes 16 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. The topics of these papers are Lung Cancer Treatments and Mutations (13 papers), HER2/EGFR in Cancer Research (7 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). B. Helfrich is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), HER2/EGFR in Cancer Research (7 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers) and collaborates with scholars based in United States, Italy and Japan. B. Helfrich's co-authors include Paul A. Bunn, David Raben, Wilbur A. Franklin, Fred R. Hirsch and Daniel C. Chan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ioannis Chatzinikolaou Breakdown of academic impact, for papers by Patrick Dunn Breakdown of academic impact, for papers by Alina Stadnitskaia Breakdown of academic impact, for papers by Tessa Baker Breakdown of academic impact, for papers by Christopher McCleese Breakdown of academic impact, for papers by C. R. Schuster Breakdown of academic impact, for papers by Daniele Bolognini Breakdown of academic impact, for papers by Issis Luque-Martínez